Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention

被引:50
|
作者
Ordovas, Jose M. [1 ]
机构
[1] Tufts Univ, Nutr & Genom Lab, USDA, Human Nutr Ctr Aging, 711 Washington St, Boston, MA 02111 USA
来源
AMERICAN JOURNAL OF CLINICAL NUTRITION | 2009年 / 89卷 / 05期
关键词
APOLIPOPROTEIN-E POLYMORPHISM; POSTPRANDIAL LIPOPROTEIN METABOLISM; PROMOTER -219G/T POLYMORPHISM; HEALTH OUTCOMES IMPLICATIONS; ACTIVATED-RECEPTOR-GAMMA; FAT DIETARY PATTERN; SERUM-LIPIDS; E PHENOTYPE; E GENOTYPE; PLASMA-LIPIDS;
D O I
10.3945/ajcn.2009.27113E
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Genetic polymorphism in human populations is part of the evolutionary process that results from the interaction between the environment and the human genome. Recent changes in diet have upset this equilibrium, potentially influencing the risk of most common morbidities such as cardiovascular diseases, obesity, diabetes, and cancer. Reduction of these conditions is a major public health concern, and such a reduction could be achieved by improving our ability to detect disease predisposition early in life and by providing more personalized behavioral recommendations for successful primary prevention. In terms of cardiovascular diseases, polymorphisms at multiple genes have been associated with differential effects in terms of lipid metabolism; however, the connection with cardiovascular disease has been more elusive, and considerable heterogeneity exists among studies regarding the predictive value of genetic markers. This may be because of experimental limitations, the intrinsic complexity of the phenotypes, and the aforementioned interactions with environmental factors. The integration of genetic and environmental complexity into current and future research will drive the field toward the implementation of clinical tools aimed at providing dietary advice optimized for the individual's genome. This may imply that dietary changes are implemented early in life to gain maximum benefit. However, it is important to highlight that most reported studies have focused on adult populations and to extrapolate these findings to children and adolescents may not be justified until proper studies have been carried out in these populations and until the ethical and legal issues associated with this new field are adequately addressed. Am J Clin Nutr 2009; 89(suppl): 1509S-17S.
引用
收藏
页码:S1509 / S1517
页数:9
相关论文
共 50 条
  • [21] A Comprehensive Review of Modifiable Cardiovascular Risk Factors and Genetic Influences in Dementia Prevention
    Khan, Mariam
    Jaiswal, Arpita
    Wandile, Bhushan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [22] CARDIOVASCULAR GENETIC RISK TESTING FOR TARGETING STATIN THERAPY IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: A COST-EFFECTIVENESS ANALYSIS
    Jarmul, Jamie A.
    Pletcher, Mark J.
    Earnshaw, Stephanie
    Weinberger, Morris
    Jonas, Daniel
    Avery, Christy
    Lich, Kristen Hassmiller
    Wheeler, Stephanie
    Pignone, Michael
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S133 - S134
  • [23] Atherosclerosis imaging for risk assessment and primary prevention of cardiovascular disease
    Grundy, SM
    PROGRESS IN CARDIOVASCULAR DISEASES, 2003, 46 (02) : 115 - 121
  • [24] Stenostiffness Approach for Cardiovascular Disease Risk Assessment in Primary Prevention
    Nakano, Hiroki
    Tomiyama, Hirofumi
    Yamashina, Akira
    HYPERTENSION, 2019, 74
  • [25] Barriers to cardiovascular disease risk scoring and primary prevention in Europe
    Hobbs, F. D. R.
    Jukema, J. W.
    Da Silva, P. M.
    McCormack, T.
    Catapano, A. L.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2010, 103 (10) : 727 - 739
  • [26] Nuts, blood lipids and cardiovascular disease
    Sabate, Joan
    Wien, Michelle
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2010, 19 (01) : 131 - 136
  • [27] Cardiovascular Disease (CVD) Risk Assessment and Prevention for Blood Donors
    Grima, K. M.
    Kessler, D.
    Valinsky, J.
    Ortiz, C.
    Kusick, M. A.
    Nandi, V.
    Vlahov, D.
    Ompad, D.
    Hillyer, C. D.
    TRANSFUSION, 2010, 50 : 33A - 34A
  • [28] Primary prevention of cardiovascular disease
    Mancia, G
    Carugo, S
    Grassi, G
    CARDIOLOGY, 1997, 88 : 32 - 37
  • [29] Primary prevention of cardiovascular disease
    Gohlke, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (1-2) : 38 - 43
  • [30] Primary prevention of cardiovascular disease
    Windler, E
    Zyriax, BC
    Beil, FU
    Greten, H
    INTERNIST, 2004, 45 (02): : 173 - 181